Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo

British Journal of Dermatology

Volumn 160, Issue 4, 2009, Pages 861-863

  Kapoor, R ^a   Phiske, M M ^a   Jerajani, H R ^a  

^a LOKMANYA TILAK MUNICIPAL GENERAL HOSPITAL   (India)

Author keywords

Repigmentation; Topical prostaglandin E2; Vitiligo

Indexed keywords

PROSTAGLANDIN E2;

ADOLESCENT; ADULT; ARTICLE; BODY SURFACE; BURNING SENSATION; CHILD; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FACE; FEMALE; GEL; GENITAL SYSTEM; HUMAN; LIP; MAJOR CLINICAL STUDY; MALE; NECK; PRIORITY JOURNAL; SCALP; SCHOOL CHILD; SKIN PIGMENTATION; TREATMENT DURATION; TREATMENT RESPONSE; TRUNK; VITILIGO;

ADMINISTRATION, CUTANEOUS; ADULT; DERMATOLOGIC AGENTS; DINOPROSTONE; FEMALE; HUMANS; MALE; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME; VITILIGO; YOUNG ADULT;

EID: 62649131125     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08923.x     Document Type: Article

References (5)

1. 2) in vitiligo - a preliminary study. Int J Dermatol 2002 41 : 942 5.
2. 2 regulates the expression of basic fibroblast growth factor messenger RNA in normal human fibroblasts. Kobe J Med Sci 2001 47 : 35 45.
3. Puri N, van der Weel MB, de Wit FS et al. Basic fibroblast growth factor promotes melanin synthesis by melanocytes. Arch Dermatol Res 1996 288 : 633 5.
4. 2 synthesis after oxidant stress is dependent on cell glutathione content. Am J Physiol Cell Physiol 1994 266 : 1392 9.
5. King RA, Oetting WS. Disorders of melanocytes. In : Fitzpatrick's Dermatology in General Medicine (Freedberg IM, Eisen AZ, Wolff K et al., eds 5th edn. New York : McGraw-Hill, 1999 945 1017.